News

After reports of patient deaths related to intracranial hemorrhage, cardiac failure, and cardiac arrest in the phase III PERSIST-2 trial, the FDA has placed a “full clinical hold” on trials exploring the tyrosine kinase inhibitor pacritinib.

Newly described research reports an upward trend in the proportion of patients with NSCLC classified as never-smokers.

One of the most commonly-affected areas of life impacted by disease and treatment

At the end of January 2016, 69 National Cancer Institute-designated cancer centers issued a statement urging parents, young adults and physicians to increase HPV vaccination rates.

Fosaprepitant dimeglumine (Emend for injection) received FDA approval as a single-dose in combination with other antiemetic agents for the prevention of delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.

The theme of World Cancer Day this year is

Decision Making and Experiences with Mastectomy for Managing Breast Cancer Risk in Women at High Risk for Breast Cancer

CancerCare is pleased to announce the availability of co-payment assistance for people diagnosed with multiple myeloma through the CancerCare Co-Payment Assistance Foundation.

Androgen-deprivation therapy, while an effective treatment for prostate cancer, can result in side effects and a reduced quality of life.

A mandate enacted after the 2010 Patient Protection and Affordable Care Act (ACA) was supposed to improve health coverage for patients enrolled in clinical trials.

The word

Individuals with detectable human papillomavirus (HPV)-16 in their mouthwash samples were 22 times more likely to develop oropharyngeal cancer (OPC) than those without the type of virus, according to findings of a new study.

The FDA has approved eribulin mesylate (Halaven) to treat patients with advanced or unresectable liposarcoma following prior treatment with an anthracycline-based chemotherapy.

Results of a recent study show that patients, caregivers, healthcare providers, and members of the general public have stronger negative attitudes toward lung cancer compared with breast cancer.

The American Cancer Society and American Society of Clinical Oncology collaborated to create survivorship guidelines to assist primary care and other clinicians in the care of women with breast cancer.

Results from clinical trials presented at the 2016 Gastrointestinal Cancers Symposium signal a role for the immunotherapy nivolumab (Opdivo) in the treatment of GI malignancies.

For practicing nurses, this may seem like a no-brainer, but a new study is offering even more evidence that quality nursing improves patient outcomes.

Short-course radiation therapy and three cycles of chemotherapy administered before surgery reduced side effects and improved overall survival (OS) when compared with standard chemoradiation for patients with locally advanced rectal cancer, new research has found.

Presidential address assures a commitment to cure cancer.

Ofatumumab (Arzerra) has been approved by the FDA as extended treatment for patients in complete or partial response following at least two lines of therapy for recurrent or progressive chronic lymphocytic leukemia (CLL).

Although survival rates are excellent for children diagnosed with retinoblastoma, new research has shown that survivors are at increased risk of developing medical problems as adults, including second cancers, especially when the disease has affected both eyes.

Breast reconstruction surgery has become an increasingly popular option among women following mastectomy, but a recent study has found that most women who opt for the procedure are ill-informed of the potential risks.

Every year, the American Cancer Society (ACS) estimates new cancer cases and deaths in the United States and compiles the most recent data on cancer incidence, mortality, and survival.

Using an individualized approach to decide whether asymptomatic women under age 50 should have mammograms is at the center of the final screening guidelines published by the US Preventive Services Task Force (USPSTF), but the group

A topical paste may prevent scarring and fibrosis caused by radiation in cancer therapy, according to a recent study led by researchers at NYU Langone

As more studies link aggressive end-of-life oncology care to problems such as suboptimal cost and quality outcomes, experts are increasingly proposing earlier, more comprehensive palliative care interventions.

Studies show that cost is a factor in patient adherence to their oral anticancer medications, but the financial burden of oral chemotherapy drugs is projected to still be too high for millions of patients even when the Medicare Part D coverage gap, or “doughnut hole,” is fully closed.

The American Psychosocial Oncology Society (APOS) has endorsed the "Psychosocial Standards of Care for Children with Cancer and Their Families" published in a December 2015 special supplement of Pediatric Blood and Cancer.